Keros Therapeutics (KROS)
(Delayed Data from NSDQ)
$56.24 USD
+1.05 (1.90%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $56.10 -0.14 (-0.25%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/2/24 |
---|---|
Current Quarter | -1.31 |
EPS Last Quarter | -1.34 |
Last EPS Surprise | 2.90% |
ABR | 1.00 |
Earnings ESP
|
2.29% |
---|---|
Current Year | -5.11 |
Next Year | -5.42 |
EPS (TTM) | -5.20 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 30.00M | NA |
# of Estimates | NA | NA | 1 | NA |
High Estimate | NA | NA | 30.00M | NA |
Low Estimate | NA | NA | 30.00M | NA |
Year ago Sales | 0.00M | 0.00M | 0.15M | 30.00M |
Year over Year Growth Est. | NA | NA | 19,768.87% | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.31 | -1.26 | -5.11 | -5.42 |
# of Estimates | 8 | 6 | 8 | 8 |
Most Recent Consensus | -1.25 | -1.70 | -5.99 | -6.98 |
High Estimate | -1.20 | -1.10 | -4.41 | -3.72 |
Low Estimate | -1.62 | -1.70 | -6.30 | -6.98 |
Year ago EPS | -1.26 | -1.27 | -5.20 | -5.11 |
Year over Year Growth Est. | -3.97% | 0.79% | 1.73% | -6.04% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 2 | 3 | 5 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 4 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.31 | -1.26 | -5.11 | -5.42 |
7 Days Ago | -1.31 | -1.26 | -5.11 | -5.42 |
30 Days Ago | -1.31 | -1.26 | -5.11 | -5.42 |
60 Days Ago | -1.29 | -1.26 | -5.01 | -5.35 |
90 Days Ago | -1.28 | -1.26 | -5.23 | -5.62 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.28 | -1.26 | -4.41 | -5.72 |
Zacks Consensus Estimate | -1.31 | -1.26 | -5.11 | -5.42 |
Earnings ESP | 2.29% | 0.00% | 13.72% | -5.54% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.34 | -1.33 | -1.27 | -1.26 | NA |
Estimate | -1.38 | -1.34 | -1.34 | -1.13 | NA |
Difference | 0.04 | 0.01 | 0.07 | -0.13 | 0.00 |
Surprise | 2.90% | 0.75% | 5.22% | -11.50% | -0.66% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more